Illumina gains after expanding Labcorp collaboration to boost NGS oncology adoption, broaden testing access, and drive growth ...

Illumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration with Veritas Genetics Powered By Fuze Health to form a consortium that aims to bring preventive genomics into everyday ...

Illumina and Labcorp expand collaboration to advance precision oncology through innovative applications of NGS solutions: San Diego Friday, March 20, 2026, 15:00 Hrs [IST] Illumin ...

New collaboration aims to bring population-scale whole-genome sequencing into everyday healthcare, enabling earlier risk detection and data-driven prevention SAN DIEGO ...

Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded ...

Shares of IlluminaILMN have risen 44.8% over the past year, reflecting strong momentum. The stock has outpaced the industry’s ...

Illumina’s fair value estimate has been adjusted slightly, moving from US$135.94 to US$136.05, signaling only a very modest ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Patient Capital Management, a value investing firm, released its “Patient Opportunity Equity Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, ...

TD Cowen 46th Annual Health Care Conference March 3, 2026 3:10 PM ESTCompany ParticipantsJacob Thaysen - CEO, Interim Chief ...

A new automated platform aims to streamline genomic sample preparation and enable standardized sequencing workflows. The technology could expand access to next-generation sequencing and support faster ...

The compounding power of Moore's Law allowed for the internet the smartphone and AI. Now Ian says it's being applied to the ...